Avita projects $76M-$81M 2025 revenue with rebound expected as claims backlog eases
Source: SeekingAlpha
2025-08-08 15:22:23 ET
More on AVITA Medical
- AVITA Medical, Inc. (RCEL) Q2 2025 Earnings Call Transcript
- AVITA Medical: Near-Perfect Execution Needed To Navigate Through Balance Sheet Challenges
- AVITA Medical GAAP EPS of -$0.38 misses by $0.12, revenue of $18.42M misses by $4.02M
- AVITA Medical Q2 2025 Earnings Preview
- Seeking Alpha’s Quant Rating on AVITA Medical
Read the full article on Seeking Alpha
For further details see:
Avita projects $76M–$81M 2025 revenue with rebound expected as claims backlog eases
Avita Medical Inc.
NASDAQ: RCEL
RCEL Trading
-3.91% G/L:
$4.42 Last:
63,395 Volume:
$4.61 Open:
RCEL Latest News
February 23, 2026 04:15:00 pm
AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference
February 12, 2026 04:01:00 pm
AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results
RCEL Stock Data
$122,429,841
29,639,304
0.44%
22
N/A
Medical Equipment & Supplies
Healthcare
US
Valencia
